Skip to content

Lidocaine and Closed-Loop Anesthesia System

Influence of Lidocaine on a Closed-Loop Anesthesia System

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01154738
Acronym
LoopLido
Enrollment
82
Registered
2010-07-01
Start date
2011-01-31
Completion date
2015-01-31
Last updated
2016-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

The objective is to evaluate the sparing effect of Lidocaine on doses of propofol and remifentanil.

Interventions

DRUGLidocaine

bolus dose of lidocaine (1.5 mg.kg-1) followed by an infusion of lidocaine (2 mg.kg-1 h-1) until the end of anesthesia. start of the induction of anesthesia 10 minutes after the bolus dose of lidocaine

DRUGPlacebo

NaCl 9/00 (same volume as in the lidocaine group) start of the induction of anesthesia 10 minutes after the bolus dose of NaCl 9/00

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients ASA 1, 2 or 3 scheduled for a general anesthesia surgical procedure (abdominal surgery, urology, ENT major procedure) lasting between 1 and 3 hours

Exclusion criteria

* age under 18 years * simultaneous general and loco-regional anesthesia * allergy to NSAID * treatment with verapamil, ketamine or gabapentin * patients receiving an opioid preoperatively * severe hepatic insufficiency * contra-indication to lidocaine * contra-indication to propofol or to remifentanil * history of central nervous system disease * patients receiving a psychotropic treatment * patients with a pace-maker

Design outcomes

Primary

MeasureTime frame
administered dose of propofol during maintenance of anesthesiaday 1

Secondary

MeasureTime frame
administered doses of remifentanil during induction and maintenance of anesthesiaday 1
delay (measured as minutes) between the end of propofol and remifentanil administration and the recovery from anesthesiaday 1
hemodynamic abnormalities requiring treatmentday 1
administered dose of propofol during induction of anesthesiaday 1
postoperative morphine requirementday 1
incidence of postoperative nausea and vomitingday 1
% of patients with an explicit memorisation of the intraoperative periodsecond postoperative day
% of time with a BIS index between 40 and 60day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026